KALEIDO BIOSCIENCES, INC. Retained Earnings
KALEIDO BIOSCIENCES, INC. had Retained Earnings of -$364.47 million as of 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-04-01
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$364.47M.
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$344.19M.
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$321.11M.
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$297.22M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2021-12-31 | -$364.47M 10-K · filed 2022-04-01 |
| 2021-09-30 | -$344.19M 10-Q · filed 2021-11-01 |
| 2021-06-30 | -$321.11M 10-Q · filed 2021-08-11 |
| 2021-03-31 | -$297.22M 10-Q · filed 2021-05-04 |
| 2020-12-31 | -$274.18M 10-K · filed 2022-04-01 |
| 2020-09-30 | -$254.16M 10-Q · filed 2020-11-02 |
| 2020-06-30 | -$231.03M 10-Q · filed 2020-08-04 |
| 2020-03-31 | -$212.11M 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$192.56M 10-K · filed 2021-03-03 |
| 2019-09-30 | -$173.05M 10-Q · filed 2019-10-30 |
| 2019-06-30 | -$151.09M 10-Q · filed 2019-08-01 |
| 2019-03-31 | -$126.45M 10-Q · filed 2019-05-02 |
| 2018-12-31 | -$106.23M 10-K · filed 2020-03-02 |